Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Shuchi Sehgal

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5026118399. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2021: 2 papers · 2022: 9 papers · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 13

  1. Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy in Patients with Early-Onset Pancreatic Cancer: Clinical Outcomes and Toxicity. Co-author DOI 10.1016/j.ijrobp.2022.07.1120↗
  2. The Timing of Surgery Following Stereotactic Body Radiation Therapy Impacts Local Control for Borderline Resectable or Locally Advanced Pancreatic Cancer. Co-author DOI 10.3390/cancers15041252↗
  3. High local failure rates despite high margin-negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients trea… First author DOI 10.1002/cam4.4527↗
  4. Efficacy and Safety of Reirradiation with Stereotactic Body Radiation Therapy for Locally Recurrent Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.clon.2021.12.014↗
  5. Location, Location, Location: What Should be Targeted Beyond Gross Disease for Localized Pancreatic Ductal Adenocarcinoma? Proposal of a Standardized Clinical … Co-author DOI 10.1016/j.prro.2022.01.005↗
  6. Multiagent Chemotherapy and Stereotactic Body Radiation Therapy in Patients with Unresectable Pancreatic Adenocarcinoma: A Prospective Nonrandomized Controlled… Co-author DOI 10.1016/j.prro.2022.02.009↗
  7. Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderlin… Co-author DOI 10.1245/s10434-021-11202-8↗
  8. High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resecta… Co-author DOI 10.21037/jgo-21-513↗
  9. Stereotactic body radiation therapy for the treatment of locally recurrent pancreatic cancer after surgical resection. Co-author DOI 10.21037/jgo-22-38↗
  10. Upfront Chemotherapy Followed by Stereotactic Body Radiation Therapy with or without Surgery in Older Patients with Localized Pancreatic Cancer: A Single Insti… First author DOI 10.3390/curroncol29010028↗
  11. Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and s… Co-author DOI 10.3857/roj.2021.01060↗
  12. Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy. Co-author DOI 10.1186/s13014-021-01969-1↗
  13. Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemot… Co-author DOI 10.3857/roj.2021.00815↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jin Peng He · 13 shared papers, 2021–2026 · strength 2.05
  2. Colin Hill · 13 shared papers, 2021–2026 · strength 2.05
  3. Joseph M. Herman · 13 shared papers, 2021–2026 · strength 2.05
  4. Amol Kumar Narang · 13 shared papers, 2021–2026 · strength 2.05
  5. Jeffrey John Meyer · 11 shared papers, 2021–2026 · strength 1.79
  6. Abhinav V. Reddy · 11 shared papers, 2021–2026 · strength 1.79
  7. Lei Zheng · 10 shared papers, 2021–2023 · strength 1.46
  8. Daniel A. Laheru · 4 shared papers, 2022 · strength 0.53
  9. Amy Hacker‐Prietz · 4 shared papers, 2021–2022 · strength 0.50
  10. Ana De Jesus‐Acosta · 3 shared papers, 2022 · strength 0.40
  11. Dung Thi Le · 3 shared papers, 2022 · strength 0.38
  12. Matthew John Weiss · 3 shared papers, 2022 · strength 0.38
  13. Lauren M. Rosati · 2 shared papers, 2022 · strength 0.26
  14. Timothy A. Lin · 1 shared paper, 2023 · strength 0.18
  15. Atif Zaheer · 1 shared paper, 2022 · strength 0.15
  16. Vincent Bernard · 1 shared paper, 2022 · strength 0.13
  17. Timothy Michael Pawlik · 1 shared paper, 2022 · strength 0.13
  18. Hao Wang · 1 shared paper, 2022 · strength 0.13
  19. Ding Ding · 1 shared paper, 2021 · strength 0.13
  20. Richard Andrew Burkhart · 1 shared paper, 2022 · strength 0.13
  21. Christopher Lee Wolfgang · 1 shared paper, 2022 · strength 0.13
  22. Ralph H. Hruban · 1 shared paper, 2022 · strength 0.13
  23. William R. Burns · 1 shared paper, 2022 · strength 0.12
  24. Valerie Lee · 1 shared paper, 2022 · strength 0.12
  25. Christopher L. Wolfgang · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.